Quinacrine hydrochloride drug eruption (tropical lichenoid dermatitis). Its early and late sequelae and its malignant potential: a review.
نویسنده
چکیده
The totality of effects of a particular drug on patients cannot be truly assessed until many patients have taken it. In order to assess the side effects of any drug, many thousands of patients may have to be observed, and the observation may have to extend over decades. Quinacrine hydrochloride (quinacrine) was used as a malarial-suppressive drug by allied soldiers during World War II. The most commonly occurring side effect was a drug eruption. This at times led to permanent sequelae at an early stage. Further observation revealed late sequelae occurring 7 to 17 years after the war. Two of these late sequelae were observed to become malignant, and in most cases the palmar aspect was involved. This is an area which rarely shows malignant change. It has been observed that quinacrine can be instrumental in inducing skin cancers as late as 34 years after its ingestion.
منابع مشابه
Molecular markers as an indicator in the malignant potential of oral lichen planus: A systematic review
BACKGROUND AND AIM: Oral lichen planus (OLP) is a chronic, autoimmune, inflammatory disease. The progression of OLP to oral squamous cell carcinoma (OSCC) has generated a longstanding controversy about the details of this malignant transformation potential. This study aimed to do a systematic review on the molecular markers related to the malignant transformation of OLP.METHODS: We searched the...
متن کاملAllergic contact dermatitis due to chlorocresol in topical corticosteroids.
services as a foreign medication or for compassionate use. The usual dose is 100mg/day, and adverse effects include yellow discoloration of mucocutaneous zones, lichenoid eruption, aplastic anemia, headache, gastrointestinal symptoms, psychosis, convulsions and worsening of psoriasis. As yellowing of the skin and the whites of the eyes is very common, patients should be advised of this side eff...
متن کاملImatinib mesylate-induced lichenoid drug eruption.
Imatinib mesylate (imatinib) is a tyrosine kinase inhibitor initially approved by the US Food and Drug Administration in 2001 for chronic myeloid leukemia (CML). Since then, the number of indicated uses for imatinib has substantially increased. It is increasingly important that dermatologists recognize adverse cutaneous manifestations of imatinib and are aware of their management and outcomes t...
متن کاملDermatitis papulosa adultorum.
Dermatitis papulosa juvenilis, also referred to as frictional lichenoid eruption, summertime lichenoid dermatitis of the elbows, Sutton's summer prurigo, recurrent papular eruption of childhood, and sandbox dermatitis, has been reported previously only in children. We describe three cases of DPJ in adults, which were confirmed by clinical and histology investigations. The term 'dermatitis papul...
متن کاملLichenoid drug eruption associated with Bendamustine
A 65-year-old man had relapsed follicular lymphoma. When he suffered a fifth relapse, he received a regimen containing bendamustine and rituximab (BR). Four weeks later, he presented with systemic erythema, swelling and bullous lesions of lips, the oral cavity, andnasal mucosa and eye pain. He could not open his mouth and had severe pain. Steven–Johnson syndrome/toxic epidermal necrolysis was d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of the American Academy of Dermatology
دوره 4 2 شماره
صفحات -
تاریخ انتشار 1981